NCT07722611 A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT07643025 Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure Status NOT_YET_RECRUITING Phase PHASE2
NCT07588945 daGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT Status NOT_YET_RECRUITING Phase PHASE3
NCT07588139 A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants Status RECRUITING Phase PHASE1
NCT07566897 A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07548983 Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation Status RECRUITING Phase PHASE1
NCT07521046 Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis) Status NOT_YET_RECRUITING Phase PHASE1
NCT07498205 Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts Status NOT_YET_RECRUITING Phase PHASE4
NCT07424222 Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE) Status RECRUITING Phase PHASE1
NCT07359859 A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT07357727 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) Status RECRUITING Phase PHASE3
NCT07356245 Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma Status RECRUITING Phase PHASE2
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE4
NCT07340723 Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) Status RECRUITING Phase PHASE2
NCT07340138 Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis Status RECRUITING Phase PHASE1
NCT07311746 Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT07252050 Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease Status RECRUITING Phase PHASE1/PHASE2